Skip to content

Pilot Trial: Comparison of Flow Patterns

Pilot Trial: Comparison of Flow Patterns. Is There a Difference Between sewed-in and Sutureless Bioprosthetic Aortic Heart Valves?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02288871
Enrollment
20
Registered
2014-11-11
Start date
2014-10-31
Completion date
2021-12-31
Last updated
2018-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Insufficiency, Aortic Valve Stenosis

Keywords

aortic valve replacement, aortic valve bioprosthesis, hemodynamics

Brief summary

The purpose of this study is to determine why sutureless aortic bioprostheses apparently offer better haemodynamic properties compared to sewed-in aortic bioprostheses in patients who underwent aortic valve replacement. Our approach to address this question is the combination of clinical data with the application of specifically validated experimental and computer based analyses to compare the performance of these valves under patient-specific conditions.

Interventions

RADIATIONCardiac CT-scan

ECG gated CT angiography of the heart will be performed on a 128-slice dual-source and two Stellar detectors CT system with retrospective ECG-gating (Siemens/SOMATOM Definition Flash - Siemens, Germany, 100kV, 395.75 mAs). In details, multi-phase images will be acquired to reconstruct between 10 and 100% of the cardiac cycle (10% increments) with a slice thickness of 1 mm. Examination will include left ventricular outflow tract, aortic root, coronary sinus, ascending aorta together with the prosthetic valves.

Sponsors

University College, London
CollaboratorOTHER
Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient underwent open aortic valve replacement with either an Edwards Magna Ease or an Edwards Intuity valve * Implanted valve size 23mm * Surgical access via full sternotomy or hemisternotomy * Intuity Valve System implanted by one of the clinical investigators of the TRITON trial (http://clinicaltrials.gov/show/NCT01445171) at the Medical University of Vienna * Post-operative ejection fraction ≥50% * Sinus-Rhythm * Ability to understand and comply with study procedures * Signed informed consent

Exclusion criteria

* Under 18 years of age * Emergency surgery * Pregnancy * Previous aortic root replacement * Previous aortic valve replacement * Previous or concomitant root enlargement * Previous or concomitant repair of the ascending aorta * Paravalvular leakage * Ectasia of the ascending aorta * Previous or concomitant myomectomy * Concomitant replacement or repair of valves other than aortic * Usage of more than 3 sutures for implantation of the Intuity Valve System * Heavily calcified aortic root * Glomerular filtration rate (GFR) \< 30 ml/min * Inability to understand or comply with study procedures * Known allergic reaction to iodinated, non-ionic contrast agents

Design outcomes

Primary

MeasureTime frame
Comparison of maximum and minimum velocity under patient specific conditionsbetween 6 months and 4 years after aortic valve replacement
Comparison of the effective orifice area under patient specific conditionsbetween 6 months and 4 years after aortic valve replacement
Comparison of the percentage of turbulent flow under patient specific conditionsbetween 6 months and 4 years after aortic valve replacement
Comparison of the pressure drop under patient specific conditionsbetween 6 months and 4 years after aortic valve replacement

Secondary

MeasureTime frameDescription
Patient-specific, computer simulated pressure gradients compared to echocardiographically obtained pressure gradients.between 6 months and 4 years after aortic valve replacementThe first secondary outcome measure is the comparison of -pressure gradients as computed by the model against the same data collected standardly with echocardiographic technique. Differences will be quantified. If positive (\< 10%), this assessment would enhance the use of patient-specific models in clinics as a predictive tool for detailed haemodynamics.
Patient-specific, computer simulated peak velocity compared to echocardiographically obtained peak velocity.between 6 months and 4 years after aortic valve replacementThe second secondary outcome measure is the comparison of -peak velocity as computed by the model against the same data collected standardly with echocardiographic technique. Differences will be quantified. If positive (\< 10%), this assessment would enhance the use of patient-specific models in clinics as a predictive tool for detailed haemodynamics.

Countries

Austria

Contacts

Primary ContactClaus Rath, MD
claus.rath@meduniwien.ac.at0043-1-40400-69660
Backup ContactMartin Andreas, MD
martin.andreas@meduniwien.ac.at0043-1-40400-69660

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026